E-therapeutics Plc (ETXPF) Research

E-therapeutics Plc is a UK-based company focused on drug discovery. The core of its work involves a sophisticated computational platform that employs in-silico screening and unique network models to identify and predict which compounds or biological targets can effectively alter relevant biological processes. Furthermore, the company is advancing an RNA interference (RNAi) platform designed for highly specific gene silencing. Founded in 2001, E-therapeutics Plc operates from its headquarters in London, United Kingdom.

Market snapshot

Symbol
ETXPF
Price
$0.13
Day change
0.00%
Market cap
$56.4M
P/E ratio
-4.71x
52-week range
0.13-0.13
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Biostage, Inc. (BSTG)
  • Ecofibre Limited (EOFBY)
  • Herantis Pharma Oyj (HRPMF)
  • Karolinska Development AB (publ) (KDEVF)
  • Mind Cure Health Inc. (MCURF)
  • Mindset Pharma Inc. (MSSTF)
  • Medivir AB (publ) (MVRBF)
  • Oncopeptides AB (publ) (ONPPF)

Open E-therapeutics Plc (ETXPF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.